Sodium Hydroxide → Methyl 2,5,7-trihydroxy-2-methyl-6,11-dioxo-4-((2,3,6-trideoxy-3-(dimethylamino)hexopyranosyl)oxy)-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate

HRID 435456ノート

反応式

HRID 435456 の反応式
[CH3:1][C@@H:2]1[O:7][C@@H:6]([O:8][C@@H:9]2[C:14]3[C:15]([OH:30])=[C:16]4[C:23](=[O:24])[C:22]5[C:25]([OH:29])=[CH:26][CH:27]=[CH:28][C:21]=5[C:19](=[O:20])[C:17]4=[CH:18][C:13]=3[C@@H:12]([C:31]([O:33][CH3:34])=[O:32])[C@@:11]([OH:36])([CH3:35])[CH2:10]2)[CH2:5][C@H:4]([N:37]([CH3:39])[CH3:38])[C@@H:3]1[O:40][C@@H:41]1[O:46][C@@H:45]([CH3:47])[C@@H:44]([O:48][C@@H]2O[C@@H](C)C(=O)CC2)[C@@H:43]([OH:57])[CH2:42]1.[OH-].[Na+]>Cl>[CH3:47][C@@H:45]1[O:46][C@@H:41]([O:40][CH:3]2[C@@H:4]([N:37]([CH3:38])[CH3:39])[CH2:5][C@H:6]([O:8][C@@H:9]3[C:14]4[C:15]([OH:30])=[C:16]5[C:23](=[O:24])[C:22]6[C:25]([OH:29])=[CH:26][CH:27]=[CH:28][C:21]=6[C:19](=[O:20])[C:17]5=[CH:18][C:13]=4[C@@H:12]([C:31]([O:33][CH3:34])=[O:32])[C@@:11]([OH:36])([CH3:35])[CH2:10]3)[O:7][C@H:2]2[CH3:1])[CH2:42][C@H:43]([OH:57])[C@@H:44]1[OH:48].[CH3:1][CH:2]1[O:7][CH:6]([O:8][CH:9]2[C:14]3[C:15]([OH:30])=[C:16]4[C:23](=[O:24])[C:22]5[C:25]([OH:29])=[CH:26][CH:27]=[CH:28][C:21]=5[C:19](=[O:20])[C:17]4=[CH:18][C:13]=3[CH:12]([C:31]([O:33][CH3:34])=[O:32])[C:11]([OH:36])([CH3:35])[CH2:10]2)[CH2:5][CH:4]([N:37]([CH3:39])[CH3:38])[CH:3]1[OH:40]

参加物

5

反応物 2

HCID 14798Sodium HydroxideHCID 155838Methyl 2,5,7-trihydroxy-2-methyl-6,11-dioxo-4-({2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-(6-methyl-5-oxooxan-2-yl)hexopyranosyl]-3-(dimethylamino)hexopyranosyl}oxy)-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate

生成物 2

HCID 174252Methyl 2,5,7-trihydroxy-2-methyl-6,11-dioxo-4-((2,3,6-trideoxy-3-(dimethylamino)hexopyranosyl)oxy)-1,2,3,4,6,11-hexahydrotetracene-1-carboxylateHCID 174332Methyl 2,5,7-trihydroxy-2-methyl-6,11-dioxo-4-((2,3,6-trideoxy-4-O-(2,6-dideoxyhexopyranosyl)-3-(dimethylamino)hexopyranosyl)oxy)-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate

試薬・触媒・溶媒 1

HCID 313Hydrochloric Acid溶媒

実験手順

A solution of 100 mg of auramycin A in 50 ml of 0.5% hydrochloric acid was hydrolyzed at room temperature for 40 minutes. The reaction mixture was neutralised by dilute sodium hydroxide solution and extracted with 100 ml of chloroform twice. The chloroform extracts were combined and concentrated in vacuo to a small volume. The concentrate was chromatographed with thin layer chromatography plates (chloroform:methanol, 5:1). The bands containing auramycin C and D were scraped off, extracted with a solvent mixture of chloroform and methanol (4:1) and concentrated in vacuo to dryness to give 12 mg of pure auramycin C and 35 mg of auramycin D.

後処理

  1. extractionextracted with 100 ml of chloroform twice
  2. concentrationconcentrated in vacuo to a small volume
  3. customThe concentrate was chromatographed with thin layer chromatography plates (chloroform:methanol, 5:1)
  4. additionThe bands containing auramycin C and D
  5. extractionextracted with a solvent mixture of chloroform and methanol (4:1)
  6. concentrationconcentrated in vacuo to dryness

出典と根拠

ORDレコード
ord-35c37e9a0e374d5ea5924cc8e4911db3
出典データセット
uspto-grants-1983_08
特許番号
US04401812

反応ノート

読み込み中…